In addition, higher PRICKLE1 expression was observed in patients with newly diagnosed AML (n = 129, P < 0.001) and relapsed AML (n = 13, P < 0.001) than in patients with complete remission (n = 35, Fig. 3b). Here, PRICKLE1 is linked to acute myeloid leukemia.